Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576160 · ClinicalTrials.gov registry record · Phase 1
Improving Medication Adherence in Post-ACS Patients
A Phase 1 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT00576160 is a Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 22 participants.
The verdict
NCT00576160, a Phase 1 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
Many post Acute Coronary Syndrome(ACS) patients do not take their medications (including aspirin) as prescribed, leading to an increase in mortality. Patients enrolled in this study will be enrolled into one of two groups. Patients in the first group will have their medication adherence measured, but will receive all other care as usual. Patients in the second group will also have their medication adherence measured, but they will receive telephone-delivered problem solving therapy (PST) in addition to their usual care. The two groups will be combined to determine the Minimally Effective Dose (MED) and the Maximally Tolerated Dose (MTD) for adherence to aspirin. The medication adherence of the PST group will improve by 20% (\<55% to \>75%).
Interventions
- BEHAVIORAL PST therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576160
The ClinicalTrials.gov registry entry for NCT00576160 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PST therapy is the first listed.
NCT00576160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576160 about?
NCT00576160 is a clinical study titled "Improving Medication Adherence in Post-ACS Patients". Many post Acute Coronary Syndrome(ACS) patients do not take their medications (including aspirin) as prescribed, leading to an increase in mortality. Patients enrolled in this study will be enrolled into one of two groups. Patients in the first group will have their medication adherence measured, bu...
What is the current status of trial NCT00576160?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2007-08. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00576160?
The interventions under investigation include: PST therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00576160?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.